Search results
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira...
WRBL Columbus· 22 hours agoCevira (APL-1702) is a photodynamic drug...
The Long, Steep Fall of an Online Education Giant
The Wall Street Journal· 22 hours agoThat pressure to lock...2U was wrongly accused of being predatory, maligned just because it was a for-profit company. Meanwhile, the company hasn’t...
Why Your Small Business Needs a Customer Retention Strategy
Motley Fool via Yahoo Finance· 2 days agoMany of the customers on your email list have likely already purchased from you. Is your email ...
Tradewinds United Media Now Offers Digital AI Receptionist Service, Payment Processing Options
Digital Journal· 6 days agoTo learn more about the digital marketing company and its cutting-edge services, visit...
Ladies hit the mini links Playing 5 to 9 in Decatur
Herald & Review· 2 days agoThe Decatur Park District hosted Playing 5 to 9, a women’s-only miniature golf event, on Thursday at the Overlook Adventure Park. Decatur residents Mary...
Short-selling news startup didn’t disclose investment in anti-hangover drink
Semafor via Yahoo Finance· 5 hours agoA new exposé by Hunterbrook Media, the startup newsroom whose affiliated company places stock market...
If You Do One Thing to Improve Customer Satisfaction, Do This
Motley Fool via Yahoo Finance· 2 days agoJust listening to your customers can help unlock big insights into how your business can...intro APR...
ADMA Biologics (NASDAQ:ADMA) Given New $10.00 Price Target at Cantor Fitzgerald
ETF DAILY NEWS· 5 hours agoA number of other analysts have also weighed in on ADMA. Mizuho upped their target price on shares of ADMA Biologics from $10.00 to $12.00 and gave the stock a buy rating in a report on Friday ...
Surefire CRM error results in 600K errant, unsolicited messages: sources
HousingWire via Yahoo Finance· 5 days agoMarketing executives across the country were surprised to discover on Monday that the “Markets in a...
Marathon Petroleum (NYSE:MPC) Downgraded by StockNews.com to Buy
ETF DAILY NEWS· 7 hours agoSeveral other brokerages have also recently commented on MPC. Barclays dropped their target price on shares of Marathon Petroleum from $221.00 to $195.00 and set an overweight rating for the ...